Our Network

We’re partnering to build a sophisticated immunotherapy industry in Australia – and beyond

Cartherics has close ties with Cell Therapies, The Peter MacCallum Cancer Centre (PMCC) Centre of Excellence in Immunotherapies, Monash University, The Australian Regenerative Medicine Institute, ToolGen Inc and a number of other institutions and companies worldwide.

In addition to its allogeneic products, Cartherics has undertaken early development of two autologous CAR-T products in collaboration with PMCC. This will undertake Phase 1 clinical trials in cutaneous T cell lymphoma and ovarian cancer.

Research Collaborations

Partnering with us

Cartherics is seeking partnerships to explore the potential of our technology across ovarian and gastric cancers.

Contact us